Free Trial
NASDAQ:SNWV

Sanuwave Health (SNWV) Stock Price, News & Analysis

Sanuwave Health logo
$35.23 +0.23 (+0.66%)
As of 04:00 PM Eastern

About Sanuwave Health Stock (NASDAQ:SNWV)

Key Stats

Today's Range
$34.50
$36.00
50-Day Range
$26.24
$39.24
52-Week Range
$5.21
$39.83
Volume
38,268 shs
Average Volume
52,098 shs
Market Capitalization
$301.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$49.00
Consensus Rating
Buy

Company Overview

Sanuwave Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

SNWV MarketRank™: 

Sanuwave Health scored higher than 45% of companies evaluated by MarketBeat, and ranked 1190th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sanuwave Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sanuwave Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sanuwave Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sanuwave Health is -7.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sanuwave Health is -7.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for SNWV.
  • Dividend Yield

    Sanuwave Health does not currently pay a dividend.

  • Dividend Growth

    Sanuwave Health does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for SNWV.
  • News Sentiment

    Sanuwave Health has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Sanuwave Health this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sanuwave Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $166,588.00 in company stock.

  • Percentage Held by Insiders

    14.90% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sanuwave Health's insider trading history.
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter.

SNWV Stock News Headlines

Trump’s SHOCKING Plan to Create MASSIVE Wealth for Americans
James Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presidential decision in modern history. According to his research, this could set off a massive wealth wave—potentially turning a $900 investment into $108,000 in under a year. It has nothing to do with tariffs or trade wars—but it’s already gaining momentum, and the window to act is closing fast.
SANUWAVE Health, Inc. (SNWV): A Bull Case Theory
See More Headlines

SNWV Stock Analysis - Frequently Asked Questions

Sanuwave Health's stock was trading at $37.61 at the beginning of 2025. Since then, SNWV stock has decreased by 6.3% and is now trading at $35.23.

Sanuwave Health Inc. (NASDAQ:SNWV) released its earnings results on Friday, May, 9th. The company reported ($0.66) earnings per share for the quarter. The business earned $9.34 million during the quarter.
Read the conference call transcript
.

Top institutional investors of Sanuwave Health include Evernest Financial Advisors LLC (0.29%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta.
View institutional ownership trends
.

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/09/2025
Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SNWV
Previous Symbol
NASDAQ:SNWV
CIK
1417663
Web
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$49.00
Low Price Target
$49.00
Potential Upside/Downside
+40.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.37 million
Net Margins
-89.86%
Pretax Margin
-89.78%
Return on Equity
N/A
Return on Assets
-145.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.40
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$32.63 million
Price / Sales
9.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.49) per share
Price / Book
-23.42

Miscellaneous

Outstanding Shares
8,570,000
Free Float
7,292,000
Market Cap
$299.01 million
Optionable
N/A
Beta
1.29

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:SNWV) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners